Physician profile
Igor Zilberman
NPI 1114050648
$34,823.42
in general payments reported to CMS, 2019-2025
39 companies · $5,463 in 2025
The $5,463 reported for 2025 was more than what 94% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,417 · 2020: $13K · 2021: $1,230 · 2022: $1,599 · 2023: $1,766 · 2024: $3,940 · 2025: $5,463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,279 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,800 · Entertainment: $65.93 · Travel and Lodging: $24.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,278.62 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,800.00 |
| Entertainment | $65.93 |
| Travel and Lodging | $24.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $16,035.16 | 2019-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Aroa Biosurgery Incorporated | $10,218.36 | 2020-2025 | |
| Smith+Nephew, INC. | $1,955.75 | 2019-2025 | Collagenase Santyl, Regranex |
| Organogenesis INC. | $1,180.15 | 2019-2025 | Puraply, Apligraf, Simplimax |
| Abbvie INC. | $1,157.98 | 2021-2025 | Dalvance |
| Convatec INC. | $832.32 | 2024-2025 | |
| Zyla Life Sciences, INC. | $532.48 | 2019-2020 | |
| Horizon Therapeutics Plc | $345.75 | 2020-2022 | |
| Polynovo North America LLC | $326.26 | 2023-2024 | Novosorb Btm |
| Stryker Corporation | $295.61 | 2019-2025 | Hoffmann, Salvation, Allowrap |
| Melinta Therapeutics, LLC | $289.70 | 2019-2025 | Orbactiv, Kimyrsa |
| Biotissue Holdings INC. | $253.86 | 2021-2025 | |
| Bioventus LLC | $209.84 | 2020-2025 | Exogen Ultrasound Bone Healing System |
| Vaporox, INC. | $147.20 | 2023 | Vht-200 Wound Treatment System |
| Paratek Pharmaceuticals, INC. | $126.48 | 2022-2025 | Nuzyra |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $102.95 | 2020-2022 | |
| Treace Medical Concepts, INC. | $86.81 | 2023-2025 | |
| Nevro Corp. | $70.47 | 2022-2023 | Senza |
| Orthofix Medical, INC. | $66.54 | 2022 | |
| Tactile Systems Technology INC | $64.57 | 2020-2023 | Entre Plus, Flexitouch Plus |
| Wright Medical Technology, INC. | $58.05 | 2019 | |
| Djo, LLC | $55.40 | 2021-2025 | Cmf |
| Solventum Corporation | $47.99 | 2024-2025 | Prevena, V.A.C. Veraflo Cleanse Choice, 3m Cavilon |
| Cashflow Solutions, LLC | $39.53 | 2024-2025 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Triad Life Sciences INC. | $31.81 | 2022 | |
| Saluda Medical Americas, INC. | $30.62 | 2024 | Evoke |
| Urgo Medical North America, LLC | $28.10 | 2023-2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Vertex Pharmaceuticals Incorporated | $27.33 | 2025 | |
| Medtronic, INC. | $26.80 | 2023 | Intellis Adaptivestim |
| Omeza LLC | $25.52 | 2024 | |
| Integra Lifesciences Corporation | $25.11 | 2020 | |
| Misonix INC | $23.11 | 2021 | |
| Acera Surgical, INC. | $21.80 | 2024 | Restrata Wound Matrix |
| Ibsa Pharma INC. | $15.95 | 2025 | Licart, Flector, Tirosint |
| Acell, INC. | $15.46 | 2020 | |
| Amniox Medical, INC. | $14.57 | 2020 | |
| Hartmann USA, INC. | $14.11 | 2025 | Zetuvit Plus 10x10 P10 |
| Allergan, INC. | $12.94 | 2019 | |
| Merck Sharp & Dohme LLC | $10.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Igor Zilberman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.